P. Suñé

发表

Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results

P. Suñé, J. Suñé, J. Montoro, 2013, PloS one.

Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients

J. A. Arranz, P. Suñé, E. Román, 2016, Therapeutic advances in gastroenterology.

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

P. Suñé, M. Pavesi, M. Navasa, 2018, Journal of hepatology.

Consent in clinical trials: what do patients know?

P. Suñé, X. Vidal, Inma Fuentes, 2010, Contemporary clinical trials.

Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study#

P. Suñé, N. Reig, R. Rojas-García, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis

P. Suñé, J. Montoro, M. Cruz, 2012, International Journal of Clinical Pharmacy.

Inhaled Tobramycin in Non—Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection with Pseudomonas Aeruginosa

P. Suñé, J. Montoro, R. Orriols, 2005, The Annals of pharmacotherapy.

Modulating Effects of Intravenous Immunoglobulins on Serum Cytokine Levels in Patients with Primary Hypogammaglobulinemia

P. Suñé, J. Montoro, S. Rodríguez, 2012, BioDrugs.

Safety of Ornithine Phenylacetate in Cirrhotic Decompensated Patients: An Open-label, Dose-escalating, Single-cohort Study

J. A. Arranz, P. Suñé, J. Córdoba, 2013, Journal of clinical gastroenterology.

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis

P. Suñé, J. Gámez, M. Deu, 2019, Therapeutic advances in neurological disorders.

Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study

S. Bielsa, P. Suñé, E. Pallisa, 2015, Lung.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study

P. Suñé, J. Joven, D. Serón, 2013, BMC Research Notes.

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

P1316 : Effects of long-term administration of midodrine and albumin in the prevention of complications in patients with cirrhosis on waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial. macht study

P. Suñé, V. Arroyo, J. Castellote, 2015 .

Midodrine and albumin for prevention of complications of cirrhosis in patients in the waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial

P. Suñé, M. Pavesi, J. Castellote, 2017 .

Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study

P. Suñé, J. Joven, D. Serón, 2013, BMC Research Notes.

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Karla P. Zepeda, Hansie M Mathelier, J. Felius, 2023, Neurology and Therapy.

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

P. Suñé, M. Pavesi, M. Navasa, 2018, Journal of hepatology.